Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Radiotherapy for the Palliation of Advanced Sarcomas-The Effectiveness of Radiotherapy in Providing Symptomatic Improvement for Advanced Sarcomas in a Single Centre Cohort.

Tween H, Peake D, Spooner D, Sherriff J.

Healthcare (Basel). 2019 Oct 18;7(4). pii: E120. doi: 10.3390/healthcare7040120.

2.

A Novel Lipidomics Workflow for Improved Human Plasma Identification and Quantification Using RPLC-MSn Methods and Isotope Dilution Strategies.

Rampler E, Criscuolo A, Zeller M, El Abiead Y, Schoeny H, Hermann G, Sokol E, Cook K, Peake DA, Delanghe B, Koellensperger G.

Anal Chem. 2018 Jun 5;90(11):6494-6501. doi: 10.1021/acs.analchem.7b05382. Epub 2018 May 10.

PMID:
29708737
3.

Harmonizing lipidomics: NIST interlaboratory comparison exercise for lipidomics using SRM 1950-Metabolites in Frozen Human Plasma.

Bowden JA, Heckert A, Ulmer CZ, Jones CM, Koelmel JP, Abdullah L, Ahonen L, Alnouti Y, Armando AM, Asara JM, Bamba T, Barr JR, Bergquist J, Borchers CH, Brandsma J, Breitkopf SB, Cajka T, Cazenave-Gassiot A, Checa A, Cinel MA, Colas RA, Cremers S, Dennis EA, Evans JE, Fauland A, Fiehn O, Gardner MS, Garrett TJ, Gotlinger KH, Han J, Huang Y, Neo AH, Hyötyläinen T, Izumi Y, Jiang H, Jiang H, Jiang J, Kachman M, Kiyonami R, Klavins K, Klose C, Köfeler HC, Kolmert J, Koal T, Koster G, Kuklenyik Z, Kurland IJ, Leadley M, Lin K, Maddipati KR, McDougall D, Meikle PJ, Mellett NA, Monnin C, Moseley MA, Nandakumar R, Oresic M, Patterson R, Peake D, Pierce JS, Post M, Postle AD, Pugh R, Qiu Y, Quehenberger O, Ramrup P, Rees J, Rembiesa B, Reynaud D, Roth MR, Sales S, Schuhmann K, Schwartzman ML, Serhan CN, Shevchenko A, Somerville SE, St John-Williams L, Surma MA, Takeda H, Thakare R, Thompson JW, Torta F, Triebl A, Trötzmüller M, Ubhayasekera SJK, Vuckovic D, Weir JM, Welti R, Wenk MR, Wheelock CE, Yao L, Yuan M, Zhao XH, Zhou S.

J Lipid Res. 2017 Dec;58(12):2275-2288. doi: 10.1194/jlr.M079012. Epub 2017 Oct 6.

4.

A Low-Pressure Oxygen Storage System for Oxygen Supply in Low-Resource Settings.

Rassool RP, Sobott BA, Peake DJ, Mutetire BS, Moschovis PP, Black JF.

Respir Care. 2017 Dec;62(12):1582-1587. doi: 10.4187/respcare.05532. Epub 2017 Sep 26.

5.

A relative quantitative positive/negative ion switching method for untargeted lipidomics via high resolution LC-MS/MS from any biological source.

Breitkopf SB, Ricoult SJH, Yuan M, Xu Y, Peake DA, Manning BD, Asara JM.

Metabolomics. 2017 Mar;13(3). pii: 30. doi: 10.1007/s11306-016-1157-8. Epub 2017 Feb 7.

6.

Ewing's sarcoma: only patients with 100% of necrosis after chemotherapy should be classified as having a good response.

Albergo JI, Gaston CL, Laitinen M, Darbyshire A, Jeys LM, Sumathi V, Parry M, Peake D, Carter SR, Tillman R, Abudu AT, Grimer RJ.

Bone Joint J. 2016 Aug;98-B(8):1138-44. doi: 10.1302/0301-620X.98B8.37346.

PMID:
27482030
7.

UK guidelines for the management of bone sarcomas.

Gerrand C, Athanasou N, Brennan B, Grimer R, Judson I, Morland B, Peake D, Seddon B, Whelan J; British Sarcoma Group.

Clin Sarcoma Res. 2016 May 4;6:7. doi: 10.1186/s13569-016-0047-1. eCollection 2016. Review.

8.

FREO2: An electricity free oxygen concentrator.

Sobott BA, Peake DJ, Black JFP, Rassool RP.

Pneumonia (Nathan). 2015 Dec 1;6:115-119. doi: 10.15172/pneu.2015.6/529. eCollection 2015.

9.

Sydenham's chorea: not gone but perhaps forgotten.

Crealey M, Allen NM, Webb D, Bouldin A, Mc Sweeney N, Peake D, Tirupathi S, Butler K, King MD.

Arch Dis Child. 2015 Dec;100(12):1160-2. doi: 10.1136/archdischild-2015-308693. Epub 2015 Sep 15.

PMID:
26374756
10.

Non-fibrosing sclerosing epithelioid fibrosarcoma: an unusual variant.

Puls F, Magnusson L, Niblett A, Douis H, Peake D, Taniere P, Kindblom LG, Mertens F.

Histopathology. 2016 Apr;68(5):760-3. doi: 10.1111/his.12791. Epub 2015 Sep 14. No abstract available.

PMID:
26212576
11.

Bunch mode specific rate corrections for PILATUS3 detectors.

Trueb P, Dejoie C, Kobas M, Pattison P, Peake DJ, Radicci V, Sobott BA, Walko DA, Broennimann C.

J Synchrotron Radiat. 2015 May;22(3):701-7. doi: 10.1107/S1600577515003288. Epub 2015 Apr 9.

12.

Perilipin 5 regulates islet lipid metabolism and insulin secretion in a cAMP-dependent manner: implication of its role in the postprandial insulin secretion.

Trevino MB, Machida Y, Hallinger DR, Garcia E, Christensen A, Dutta S, Peake DA, Ikeda Y, Imai Y.

Diabetes. 2015 Apr;64(4):1299-310. doi: 10.2337/db14-0559. Epub 2014 Nov 12.

13.

Neurological manifestations of influenza infection in children and adults: results of a National British Surveillance Study.

Goenka A, Michael BD, Ledger E, Hart IJ, Absoud M, Chow G, Lilleker J, Lunn M, McKee D, Peake D, Pysden K, Roberts M, Carrol ED, Lim M, Avula S, Solomon T, Kneen R.

Clin Infect Dis. 2014 Mar;58(6):775-84. doi: 10.1093/cid/cit922. Epub 2013 Dec 18.

PMID:
24352349
14.

Benign hereditary chorea related to NKX2.1: expansion of the genotypic and phenotypic spectrum.

Peall KJ, Lumsden D, Kneen R, Madhu R, Peake D, Gibbon F, Lewis H, Hedderly T, Meyer E, Robb SA, Lynch B, King MD, Lin JP, Morris HR, Jungbluth H, Kurian MA.

Dev Med Child Neurol. 2014 Jul;56(7):642-8. doi: 10.1111/dmcn.12323. Epub 2013 Oct 31.

15.

Adherence to antiepileptic medicines in children: a multiple-methods assessment involving dried blood spot sampling.

Shah NM, Hawwa AF, Millership JS, Collier PS, Ho P, Tan ML, Peake D, Tirupathi S, Bothwell J, Bailie N, Shepherd C, Craig J, McElnay JC.

Epilepsia. 2013 Jun;54(6):1020-7. doi: 10.1111/epi.12126. Epub 2013 Feb 28.

16.

Success and failure of dead-time models as applied to hybrid pixel detectors in high-flux applications.

Sobott BA, Broennimann Ch, Schmitt B, Trueb P, Schneebeli M, Lee V, Peake DJ, Elbracht-Leong S, Schubert A, Kirby N, Boland MJ, Chantler CT, Barnea Z, Rassool RP.

J Synchrotron Radiat. 2013 Mar;20(Pt 2):347-54. doi: 10.1107/S0909049513000411. Epub 2013 Jan 30.

17.

You're the flight surgeon: endocarditis.

Peake DE.

Aviat Space Environ Med. 2012 Oct;83(10):1013-5. No abstract available.

PMID:
23066628
18.

Improved count rate corrections for highest data quality with PILATUS detectors.

Trueb P, Sobott BA, Schnyder R, Loeliger T, Schneebeli M, Kobas M, Rassool RP, Peake DJ, Broennimann C.

J Synchrotron Radiat. 2012 May;19(Pt 3):347-51. doi: 10.1107/S0909049512003950. Epub 2012 Mar 16.

19.

Use of national tariff makes formula inaccurate.

Peake D, Parry R, Mustfa N, Hussain I.

BMJ. 2011 Jan 4;344:d8175; author reply d8184. doi: 10.1136/bmj.d8175. No abstract available.

PMID:
22218600
20.

Prognostic factors and metastatic patterns in primary myxoid/round-cell liposarcoma.

Haniball J, Sumathi VP, Kindblom LG, Abudu A, Carter SR, Tillman RM, Jeys L, Spooner D, Peake D, Grimer RJ.

Sarcoma. 2011;2011:538085. doi: 10.1155/2011/538085. Epub 2011 Nov 28.

21.

The 'other' bone sarcomas: prognostic factors and outcomes of spindle cell sarcomas of bone.

Pakos EE, Grimer RJ, Peake D, Spooner D, Carter SR, Tillman RM, Abudu S, Jeys L.

J Bone Joint Surg Br. 2011 Sep;93(9):1271-8. doi: 10.1302/0301-620X.93B9.27166.

PMID:
21911541
22.

The inpatient neurology consultation service: value and cost.

Douglas MR, Peake D, Sturman SG, Sivaguru A, Clarke CE, Nicholl DJ.

Clin Med (Lond). 2011 Jun;11(3):215-7.

23.

Reducing plasma membrane sphingomyelin increases insulin sensitivity.

Li Z, Zhang H, Liu J, Liang CP, Li Y, Li Y, Teitelman G, Beyer T, Bui HH, Peake DA, Zhang Y, Sanders PE, Kuo MS, Park TS, Cao G, Jiang XC.

Mol Cell Biol. 2011 Oct;31(20):4205-18. doi: 10.1128/MCB.05893-11. Epub 2011 Aug 15.

24.

Oncological outcomes of patients with Ewing's sarcoma: is there a difference between skeletal and extra-skeletal Ewing's sarcoma?

Pradhan A, Grimer RJ, Spooner D, Peake D, Carter SR, Tillman RM, Abudu A, Jeys L.

J Bone Joint Surg Br. 2011 Apr;93(4):531-6. doi: 10.1302/0301-620X.93B4.25510.

PMID:
21464495
25.

UK Guidelines for the Management of Bone Sarcomas.

Grimer R, Athanasou N, Gerrand C, Judson I, Lewis I, Morland B, Peake D, Seddon B, Whelan J.

Sarcoma. 2010;2010:317462. doi: 10.1155/2010/317462. Epub 2010 Dec 29.

26.

Selective reduction in the sphingomyelin content of atherogenic lipoproteins inhibits their retention in murine aortas and the subsequent development of atherosclerosis.

Fan Y, Shi F, Liu J, Dong J, Bui HH, Peake DA, Kuo MS, Cao G, Jiang XC.

Arterioscler Thromb Vasc Biol. 2010 Nov;30(11):2114-20. doi: 10.1161/ATVBAHA.110.213363. Epub 2010 Sep 2.

27.

Guidelines for the management of soft tissue sarcomas.

Grimer R, Judson I, Peake D, Seddon B.

Sarcoma. 2010;2010:506182. doi: 10.1155/2010/506182. Epub 2010 May 31.

28.

Neurologic problems after pediatric liver transplantation and combined liver and bowel transplantations: a single tertiary centre experience.

Fernandez D, El-Azzabi TI, Jain V, Lloyd C, Wassmer E, Peake D, Gupte GL.

Transplantation. 2010 Aug 15;90(3):319-24. doi: 10.1097/TP.0b013e3181e5b7fc.

PMID:
20574418
29.

Impaired de novo choline synthesis explains why phosphatidylethanolamine N-methyltransferase-deficient mice are protected from diet-induced obesity.

Jacobs RL, Zhao Y, Koonen DP, Sletten T, Su B, Lingrell S, Cao G, Peake DA, Kuo MS, Proctor SD, Kennedy BP, Dyck JR, Vance DE.

J Biol Chem. 2010 Jul 16;285(29):22403-13. doi: 10.1074/jbc.M110.108514. Epub 2010 May 7.

30.

Liver-specific deficiency of serine palmitoyltransferase subunit 2 decreases plasma sphingomyelin and increases apolipoprotein E levels.

Li Z, Li Y, Chakraborty M, Fan Y, Bui HH, Peake DA, Kuo MS, Xiao X, Cao G, Jiang XC.

J Biol Chem. 2009 Sep 25;284(39):27010-9. doi: 10.1074/jbc.M109.042028. Epub 2009 Aug 1.

31.

Gastrointestinal stromal tumour with a KIT exon 11 mutation presenting as a paratesticular mass.

Hilman S, Sothi S, Peake D, Andersson J, Meis JM.

Br J Radiol. 2009 May;82(977):e98-e101. doi: 10.1259/bjr/99331669.

PMID:
19386957
32.

Sphingomyelin synthase 2 is one of the determinants for plasma and liver sphingomyelin levels in mice.

Liu J, Zhang H, Li Z, Hailemariam TK, Chakraborty M, Jiang K, Qiu D, Bui HH, Peake DA, Kuo MS, Wadgaonkar R, Cao G, Jiang XC.

Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):850-6. doi: 10.1161/ATVBAHA.109.185223. Epub 2009 Mar 12.

33.

Common acute oncological emergencies: diagnosis, investigation and management.

Walji N, Chan AK, Peake DR.

Postgrad Med J. 2008 Aug;84(994):418-27. doi: 10.1136/pgmj.2007.067033. Review.

PMID:
18832403
34.

A phase II clinical trial of gemcitabine and split dose cisplatin in advanced non-small cell lung cancer in an outpatient setting.

Hussain SA, Palmer DH, Swinson DE, Riley P, Wills A, Brown C, Draycott C, El-Modir A, Peake DR, Rea DW, Chetiyawardana AD, Cullen MH.

Oncol Rep. 2008 Jul;20(1):233-7.

PMID:
18575742
35.

Sphingomyelin synthase 2 deficiency attenuates NFkappaB activation.

Hailemariam TK, Huan C, Liu J, Li Z, Roman C, Kalbfeisch M, Bui HH, Peake DA, Kuo MS, Cao G, Wadgaonkar R, Jiang XC.

Arterioscler Thromb Vasc Biol. 2008 Aug;28(8):1519-26. doi: 10.1161/ATVBAHA.108.168682. Epub 2008 Jun 19.

PMID:
18566297
36.

Paget's Osteosarcoma - no Cure in Sight.

Shaylor PJ, Peake D, Grimer RJ, Carter SR, Tillman RM, Spooner D.

Sarcoma. 1999;3(3-4):191-2. doi: 10.1080/13577149977631.

37.

Use of imatinib mesylate in gastrointestinal stromal tumours: Pan-Birmingham Cancer Network experience.

Wong DW, Lupton SC, Bhatt L, Gross L, Tanière P, Peake DR, Spooner D, Geh JI.

Clin Oncol (R Coll Radiol). 2008 Sep;20(7):517-22. doi: 10.1016/j.clon.2008.04.008. Epub 2008 Jun 2.

PMID:
18514495
38.

Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN).

Kurian MA, Morgan NV, MacPherson L, Foster K, Peake D, Gupta R, Philip SG, Hendriksz C, Morton JE, Kingston HM, Rosser EM, Wassmer E, Gissen P, Maher ER.

Neurology. 2008 Apr 29;70(18):1623-9. doi: 10.1212/01.wnl.0000310986.48286.8e.

PMID:
18443314
39.

Soft-tissue sarcomas of the hand: oncological outcome and prognostic factors.

Pradhan A, Cheung YC, Grimer RJ, Peake D, Al-Muderis OA, Thomas JM, Smith M.

J Bone Joint Surg Br. 2008 Feb;90(2):209-14. doi: 10.1302/0301-620X.90B2.19601.

PMID:
18256090
40.

AGPAT6 is a novel microsomal glycerol-3-phosphate acyltransferase.

Chen YQ, Kuo MS, Li S, Bui HH, Peake DA, Sanders PE, Thibodeaux SJ, Chu S, Qian YW, Zhao Y, Bredt DS, Moller DE, Konrad RJ, Beigneux AP, Young SG, Cao G.

J Biol Chem. 2008 Apr 11;283(15):10048-57. doi: 10.1074/jbc.M708151200. Epub 2008 Jan 31.

41.

Management of children with Guillain-Barré syndrome.

Agrawal S, Peake D, Whitehouse WP.

Arch Dis Child Educ Pract Ed. 2007 Dec;92(6):161-8. Review. No abstract available.

PMID:
18032711
42.

Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization.

Li Z, Hailemariam TK, Zhou H, Li Y, Duckworth DC, Peake DA, Zhang Y, Kuo MS, Cao G, Jiang XC.

Biochim Biophys Acta. 2007 Sep;1771(9):1186-94. Epub 2007 Jun 6.

43.

Retention rate of levetiracetam in children with intractable epilepsy at 1 year.

Peake D, Mordekar S, Gosalakkal J, Mukhtyar B, Buch S, Crane J, Wheway R, Rittey C, Donnelly J, Whitehouse WP, Philip S.

Seizure. 2007 Mar;16(2):185-9. Epub 2007 Jan 26.

44.

Does the method of treatment affect the outcome in soft-tissue sarcomas of the adductor compartment?

Pradhan A, Cheung YC, Grimer RJ, Abudu A, Peake D, Ferguson PC, Griffin AM, Wunder JS, O'Sullivan B, Hugate R Jr, Sim FH.

J Bone Joint Surg Br. 2006 Nov;88(11):1480-6.

PMID:
17075094
45.

Treatment of gastric cancer.

Fielding J, Peake D.

N Engl J Med. 2006 Sep 28;355(13):1386-7; author reply 1387-8. No abstract available.

PMID:
17014034
46.

Analytical and biological evaluation of high throughput screen actives using evaporative light scattering, chemiluminescent nitrogen detection, and accurate mass LC-MS-MS.

Peake DA, Duckworth DC, Perun TJ, Scott WL, Kulanthaivel P, Strege MA.

Comb Chem High Throughput Screen. 2005 Sep;8(6):477-87.

PMID:
16178807
47.

Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation.

Wilson J, Connock M, Song F, Yao G, Fry-Smith A, Raftery J, Peake D.

Health Technol Assess. 2005 Jul;9(25):1-142. Review.

48.

Results from a bench marking survey on Supporting Chemical Synthesis and Structural Elucidation in the Pharmaceutical Industry.

Peake DA, Ackermann BL.

J Am Soc Mass Spectrom. 2005 Apr;16(4):599-605. No abstract available.

PMID:
15871168
49.

A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer.

Hussain SA, Stocken DD, Riley P, Palmer DH, Peake DR, Geh JI, Spooner D, James ND.

Br J Cancer. 2004 Aug 31;91(5):844-9.

50.

Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancer.

Hussain SA, Stocken DD, Peake DR, Glaholm JG, Zarkar A, Wallace DM, James ND.

Br J Cancer. 2004 Jun 1;90(11):2106-11.

Supplemental Content

Support Center